Track this weekly and note it alongside your dose, any dose changes, and any new management strategies you implemented
In Lansing, Michigan, our providers assess medical history, current medications, lifestyle, and goals to craft an ideal treatment plan for you
Flament, S., Delacourte, A., Verny, M., Hauw, J
Decide if your product is a medicine or a medical device
Thank you so much to Patricia Jakel, Sriram Machineni and Neil Iyengar for sharing your perspective and insight with me for Oncology Nursing News & MJH Life Sciences
The mean (95% CI) change from baseline at week 48 in the Symptoms component was 5.76 (7.42, 4.10) for glycopyrrolate/eFlow CS and 6.71 (8.69, 4.73) for tiotropium (Figure 3c)